Physiologic principles underlying the differences in fetal hemoglobin (HbF) induction between acute and chronic states of erythroid expansion are poorly understood. Whereas abrupt erythroid expansion is characterized by a high proportion of reticulocytes coexpressing adult and fetal globin (F reticulocytes), HbF levels wane with chronic erythropoietic stimulation. To investigate this phenomenon, w e used various schedules of erythropoietin (epo) administration in primates. Acute intravenous epo administration promoted a 2-to 1 0-fold preferential induction of F reticulocytes compared with total reticulocytes. Total reticulocyte and F reticulocyte production were significantly correlated (correlation coefficient .41 to .74). With chronic epo administration, preferential F reticulocyte production was lost, and there was no correlation between reticulocyte and HE TERM STRESS erythropoiesis describes states of T red blood cell (RBC) expansion that occur in response to proliferative signals. When RBC expansion is abrupt, such as occurs after acute hemolysis,' blood loss,* during the recovery phase of transient erythroblastopenia of childhood: or after bone marrow tran~plantation,~ fetal hemoglobin (HbF) is induced. In contrast, circumstances of long-term erythroid expansion (such as occur in chronic hemolytic anemias) are associated with lesser levels of HbF i n d~c t i o n .~,~ Mechanisms underlying the differences in HbF between acute and chronic erythroid stimulation have not been elucidated. To better understand these differences, we have studied the effect of various schedules of erythropoietin (epo) administration on HbF production in primates.
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MATERIALS AND METHODS

Animals.
Baboons (Papio cynocephalus) were housed and cared for at the Regional Primate Center, University of Washington. The human recombinant epo used was provided by Genetics Institute (Boston, MA) and was more than 99% pure. Epo was diluted in 5% glucose (in phosphate-buffered saline [PBS] ) and 0.05% human albumin. Doses of epo were administered intravenously (IV) over 5 minutes or subcutaneously (as indicated). All animals received iron supplementation (iron dextran 100 mg), vitamin B,* (100 mg), and folic acid (5 mg) every week.
Hemoglobin, packed cell volume, RBCs, white blood cells (WBCs), platelets, and hematocrit were measured by standard methodology. Relative numbers of reticulocytes were assessed in preparations stained with brilliant cresyl blue (BCB) by counting a total of 2,000 cells. HbF was quantitated by the method of Betke et a1. 6 The proportion of HbF containing reticulocytes (F reticulocytes) was evaluated after immunochemical staining of the reticulocyte preparations as described previousl$; in brief, RBCs were first incubated with BCB to induce reticulum formation; smears were prepared, fixed in methanol, and labeled with the anti-y-chain monoclonal antibody (MoAb) and anti-mouse F(ab'), fluorescein isothiocyanate (FITC) in the presence of 0.005% acridine orange. With this method, the precipitated reticulum in F reticulocytes appears red-orange on a green background; adult (A) reticulocytes show the red-orange reticulum on a black background. The preparations were viewed in a Zeiss Universal fluorescent microscope (Oberkochen, Germany) and approximately 1,000 cells in different fields were evaluated for each slide. Reticulocyte-enriched preparations were made wherever necessary to enhance accuracy of counting. For measure-
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F reticulocyte production (correlation coefficient -.03). The mean percentage of F reticulocytes did not change between acute and chronic schedules of epo administration. The subcutaneous route of high-dose (3,000 U/kg) epo administration was as effective as intravenous administration in the induction of HbF. Reticulocyte and F reticulocyte responses to increasing epo doses were found to be saturable. These results suggest that the kinetics rather than absolute levels of reticulocyte and F reticulocyte response form the basis for preferential F reticulocyte induction with acute erythropoietic stimulation, and they support the hypothesis that F reticulocytes arise from a relatively rapid pathway of erythroid maturation.
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ments of globin biosynthesis, reticulocyte-rich samples were incubated with [3H]leucine in leucine-free Iscove's modified Dulbecco's medium and 10% fetal calf serum at 37°C overnight. At the end of incubation, the samples were washed, lysed, and used for isoelectric focusing of globin chains.* The relative proportions of synthesized globin chains were determined by automated densitometry of the fluorograms.
Measurement of epo was performed by a conventional radioimmunoassay (RIA) method. In brief, epo was radiodinated and bound to a rabbit antiepo antibody, raised to a crude urinary epo sample. Binding was measured in the presence of unlabeled standard amounts of recombinant human epo (Amgen, Thousand Oaks, CA) after precipitation with goat anti-rabbit antisera and normal rabbit serum as a camer. Standard curves are sigmoid when plotted as counts per minute (cpm) precipitated versus log milliunits of epo. Calculations were performed using a National Institutes of Health RIA program developed by D. Rodbard, Y . Feldman, and M. Yaffe (version of October 1976, modified July, 1979) and run on a HewlettPackard model 9870 computer (Santa Clara, CA). The RIA used in the present study included in each run a standard serum sample and had a day-to-day coefficient of variation of 6%. The sensitivity varies for each assay generally between a threshold of 2 and 3 mU of epo in 0.3 mL of sample.
Epo assay.
RESULTS
Changes in reticulocyte and F reticulocyte production with acute erythroid stimulation. Conditions of acute erythroid expansion were established by the intermittent IV adminis-For personal use only. on October 30, 2017. by guest www.bloodjournal.org From tration of erythropoietin (epo). Five nonanemic baboons received IV boluses of epo. In animals receiving multiple administrations, doses were separated by 7 or more days. Total doses of epo ranged between 800 and 9,000 U/kg, divided over two injections on a single day. The percentages of reticulocytes and F reticulocytes were measured between 3 and 10 days after epo administration. As shown in Fig 1, a sig nificant association between the percentage of reticulocytes and percentage of F reticulocytes was observed in all animals, with correlation coefficients in animals A, B, C, D, and E of 0.74, 0.64, 0.42, 0.62, and 0.54, respectively. These correlations were statistically significant to a level of <.OS, <.OO 1, <.O 1, <. 1, and <.OO 1, respectively. Slopes of the regression lines (in the same order) were 4.0, 6.8, 2.6, 9.6, and 3.4, suggesting a 2-to IO-fold greater relative induction of F reticulocytes compared to total reticulocytes. The results are consistent regardless of whether animals received a single or multiple injections of epo separated by I or more weeks.
Because short courses of epo administration appeared to favor the production of F reticulocytes out of proportion to reticulocytes containing adult globin only (A reticulocytes), we sought to determine whether this relationship is altered under conditions of chronic erythroid stimulation. Therefore, two different schedules of epo were administered sequentially in a single animal. Epo, 3,000 U/kg every 12 hours for two doses was administered IV once weekly for 13 weeks, followed by an increase to thrice weekly for 7 weeks. The thrice-weekly schedule was administered IV for the first 2 weeks and subcutaneously (SC) for the subsequent 5 weeks. Figure 2 shows the relative and absolute changes in reticulocytes and F reticulocytes that occurred during the course of treatment. During the period of weekly epo administration, waves of reticulocytes were observed with percent reticulocytes ranging from 2% to 7%, with a mean of 3.8%, and an absolute reticulocyte count mean of 2 17 X 109/L. With the thrice-weekly schedule, the waves of reticulocytes are temporally compressed and elevated to mean levels of 9.296, with a mean absolute reticulocyte count of 524 X 109/L. With one exception, the reticulocyte nadir during the period of frequent epo administration did not decrease below 4%; showing that this schedule successfully promoted continuous erythroid stimulation. In comparison, wide swings in the percentages of F reticulocytes in response to weekly epo administration were dampened with the more frequent dosage schedule. The total number of F reticulocytes increased from 40.8 X 109/L with weekly administration to 102.3 X 109/L with the more frequent schedule. However, it is noteworthy that throughout the course of treatment the mean percentage of F reticulocytes did not significantly change, with a mean of 19.8% during weekly epo administration and 19.6% during thrice-weekly administration. The correlation between F reticulocyte and total reticulocyte production was examined during the period of chronic epo administration, and it is shown in Fig 3. The correlation coefficient of this relationship is -.03, and the slope of the regression line is -.08. These results suggest that the significant correlation between total reticulocyte and F reticulocyte production during acute erythroid stimulation disappears with chronic expansion. Additionally, in the tranEffect of chronic erythroid stimulation. Reticulocytes, '1. sition from intermittent to continuous erythroid stimulation, the 2-to IO-fold preferential induction of F reticulocytes is lost.
F reticulocyte response with IV versus subcutaneous erythropoietin administration. To determine whether there are differences in F reticulocyte response to different routes of epo administration, two baboons were treated at two different times with a single dose of either IV or SC epo, at 3,000 U/ kg. Peripheral blood was drawn at times 0, I , 2, 3, 4, 5, 6, 10,24,48, and 72 hours after injection, and epo levels in the serum were determined using RIA. The results of one of these experiments are shown in Fig 4. IV administration resulted in a sharp transient peak in serum epo levels of 18,000 mU/mL, which decreased rapidly to under 2,000 mU/mL in less than 12 hours and to pre- Days of Treatment treatment levels within 2 days. In contrast, SC administration of the same dose resulted in a gradual increase to a peak value of 5,500 mU/mL, which decreased very slowly to reach under 2,000 mU/mL in 24 hours and to pretreatment levels in 3 to 4 days. The area under the curve (AUC) of epo concentrations with IV administration was 88% of that found with SC epo administration. Total reticulocytes peaked at 5% 4 days after IV epo and at 3% 4 days after SC epo. F reticulocytes peaked at 17% 6 days following IV epo and maximized at 25% 7 days after SC epo administration. Similar results were obtained in a second animal, in which reticulocyte globin chain biosynthetic ratios are shown in Table 1 . Comparison of the response in the percentage of reticulocytes, percentage of F reticulocytes, and y/(y + p) biosynthetic ratios to the different routes of administration permits two observations. First, maximal HbF induction after IV epo administration occurred 1 to 2 days more rapidly than following SC administration. Second, the SC route was at least as effective as the IV route in the induction of HbF. This occurred despite the higher peak epo levels associated with the IV route, suggesting that maximal F reticulocyte response occurs at the lower epo concentrations achieved with the SC route and that the ability to respond to epo is saturable.
To specifically test whether saturation kinetics in F-reticulocyte response occur with increasing doses of epo, two animals were treated with sequentially escalating IV doses. In Fig 5 are plotted the maximum levels of reticulocytes and F reticulocytes obtained at each dose of epo used. Animal A received epo in doses ranging from 1,000 U/kg to 10,000 U/kg. Reticulocyte and F-reticulocyte levels plateaued at 2,000 to 3,000 U/kg. Animal B was treated with doses ranging from 1,000 U/kg to 18,000 U/kg. Increasing doses of epo elicited increasing reticulocyte and F reticulocyte responses. A plateau in F-reticulocyte reDose-response experiments. 
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sponse was suggested at epo doses exceeding 8,000 U/kg; at the same dose, the rate of increase in reticulocytes also began to level. These results suggest that the linearity of epo dose to reticulocyte and F reticulocyte response is variable and, in some instances, may be lost only at high doses.
DISCUSSION
Many clinical*3327 and observations support the generalization that states of acute erythroid expansion lead to induction of HbF, whereas states of chronic erythroid stimulation are associated with little or no HbF induction.4.' In vitro'' and in vivo" studies have suggested that early erythroid precursors maintain the capacity for primitive globin expression and that this capacity is lost in most cells during These observations led to the proposal' that in states of rapid marrow expansion, accelerated maturation of early erythroid precursors yields progeny that maintain a partially fetal program of expression. In contrast, chronic erythroid stimulation results in replenishment of late pools of erythroid precursors, thus allowing normal RBC maturation to resume, and is reflected in no further increase in levels of HbF. Observations presented here are consistent with this model and allow it to be expanded. From data presented in Figs 1 through 3 , the following conclusions are suggested.
First, the correlation between reticulocyte and F reticulocyte production characteristic of acute erythroid stimulation is lost with chronic expansion. Second, preferential induction of F reticulocytes occurs only under circumstances of acute marrow expansion. The marked preference for the formation of F reticulocytes over A reticulocytes in acute expansion compared to chronic expansion is not a consequence of elevated mean F-reticulocyte percentages in acute expansion. In fact, the mean F-reticulocyte percentage is remarkably similar between acute and chronic stimulation. An expla- nation for this apparent paradox is proposed in Fig 6. This diagram depicts the effects of two phenomena: ( I ) the preferential induction of F reticulocytes with acute stimulation and ( 2 ) the significant correlation between reticulocyte and F-reticulocyte production with acute intermittent stimulation that disappears with continuous stimulation. In states of acute expansion, maximal F-reticulocyte production generally occurs synchronously with maximal total reticulocyte production. This "peak on peak" effect permits F reticulocytes to have an exaggerated contribution to the total reticulocyte output over time. However, in chronic expansion, although the mean percentage of F reticulocytes is identical to that of the acute state, the peak (and trough) F-reticulocyte percentages are markedly dampened. Additionally, the correlation between percentages of F reticulocytes and reticulocytes is lost, leaving the vestigial peaks in F-reticulocyte production unassociated with the peaks in total reticulocyte production. Thus, in states of chronic expansion, F reticulocytes have a lesser contribution to total reticulocyte production over time.
A I
These results may provide clues regarding the physiologic processes governing F reticulocyte production. We have suggested a model proposing that F reticulocytes arise from the accelerated differentiation of erythroid progenitors that maintain a partially fetal program of expression,' presumably because of the persistence of fetal stage-specific transcription factors. An interpretation of our results in the context of this model is given in Fig 7. This expanded model proposes that erythroid development can be broadly divided into two pathways of maturation, differing with regard to the time required to produce reticulocytes.
The more rapid pathway of differentiation produces a relatively high proportion of F reticulocytes, and it may result Hours after Injection from a sacrifice in either the number of divisions or cell cycle time required for maturation. It is noteworthy that if the slower pathway requires more divisions, it will contribute disproportionately to the total reticulocyte output. Under conditions of basal erythropoiesis, reticulocyte output arises mainly from the slower pathway of differentiation (Fig 7A) . In states of erythroid expansion (depicted in Fig 7, B through  D) , differentiation via the rapid pathway is favored. In the first stage of acute expansion (Fig 7B) , relatively more mature erythroid precursors within the slow pathway quickly enter and complete maturation via the more rapid pathway, temporarily depleting pools of mature erythroid precursors. An evanescent early wave of A reticulocytes (before the rise in F reticulocytes) would be anticipated. This is consistent with findings reported by AI-Khatti et a1,' who, after the acute administration of high doses of epo in chronically anemic baboons, noted an increment in total reticulocytes 2 days before the corresponding increase in F reticulocytes. The resulting situation is shown in Fig 7C, where, in the setting of 
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few mature precursors, the rapid pathway contributes predominantly to reticulocyte output, yielding a high proportion of F reticulocytes. The significant correlation between total reticulocyte and F-reticulocyte production we observed with acute expansion (correlation coefficients between 0.42 and 0.74) is consistent with the hypothesis that most reticulocytes during this phase result from the same kinetic pathway. Figure  7D shows the situation with chronic erythroid expansion, in which both paths contribute significantly to the total reticulocyte output. Thus, one would expect little or no correlation between total reticulocyte and F-reticulocyte production in chronic erythroid expansion as was observed in Fig 3 ( correlation coefficient -.03). Predictions based on this model may at first appear to be in conflict with observations reported by Dover et al,7 in which F reticulocytes increased synchronously with total reticulocytes in two girls recovering from transient erythroblastopenia of childhood. We hypothesize that the early increase in A reticulocytes observed in our studies did not occur in these patients because they lacked Arrows on the left-hand side of each panel represent a relatively slow pathway of erythroid differentiation that yields few F reticulocytes.
Arrows on the right-hand side of each panel represent a relatively rapid pathway of differentiation that yields a high proportion of F reticulocytes.
During basal production (A), both pathways may contribute to total reticulocyte production, but the slower pathway will be disproportionately represented if it contains more divisions. With acute expansion, precursors within the slower pathway shift to the rapid pathway (6). As these precursors are relatively mature, an evanescent wave of (A) reticulocytes may be observed. Following temporary depletion of the mature precursor pools in the slower pathway, reticulocytes arise mainly from the rapid pathway (C), resulting in perferential F-reticulocyte production and a strong correlation between reticulocyte and F-reticulocyte output. With chronic expansion (D), mature precursor pools within the slower pathway are replenished and preferential F-reticulocyte production is lost.
pools of mature precursors at the time when rapid erythroid regeneration began. Nevertheless, this example emphasizes that differences exist between our experimental model and states of acute and chronic erythroid stimulation as they occur clinically. Additionally, peak serum levels of epo measured in this study (5,000 to 18,000 mU/mL, Fig 4) far surpass peak epo levels measured in patients who are nonhypoplastic with acute blood loss (250 mU/mL), but they are more similar to peak levels measured in hypoplastic patients (250 to 15,000 mU/mL).I4 The optimal doses, schedules, and routes of epo administration for HbF induction have not been determined. The observation that SC epo administration yielded at least as great an F reticulocyte response as the same dose administered IV suggests that epo receptors present on precursor cells capable of becoming F reticulocytes were already maximally stimulated at the lower epo concentrations achieved with the SC route. Dose-escalation studies in two additional animals were consistent with this hypothesis.
Many therapeutic strategies for HbF induction in disorders of globin-chain synthesis involve the perturbation of erythroid kinetics. Understanding of the relationship between erythroid development and HbF induction may provide exploitable clues to be applied in the treatment of these disorders.
